Search
for
Sort by
Research 331–360 of 693
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Marie Unna Hereditary Hypotrichosis Gene Maps to Human Chromosome 8p21 Near Hairless
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Dermoscopic findings of alopecia areata in dark skinned individuals: An analysis of 116 cases
- Dermoscopy of alopecia areata in restrospective analysis
- Serum level of vitamin D in patients with alopecia areata
- MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata
- Triamcinolone Acetonide Mesotherapy in the Treatment of Recalcitrant Patches of Alopecia Areata - A Pilot Study
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- Common causes of paediatric alopecia
- Marie Unna Hereditary Hypotrichosis Gene Maps to Human Chromosome 8p21 Near Hairless
- Anxiety, depression, and quality of life in children and adults with alopecia areata: A systematic review and meta-analysis
- The Multi-Faceted Role of Gut Microbiota in Alopecia Areata
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- The Use of 308-nm Excimer Laser Therapy in Alopecia Areata and Primary Cicatricial Alopecia: A Systematic Review
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Simultaneous Alopecia Areata in Identical Twins: First Case Reported in Saudi Arabia
- National, Regional, and Global Epidemiology of Alopecia Areata: A Systematic Analysis Based on Modeling Study
- The role of hsa‐miR‐193a‐5p as an important factor for control of inositol in alopecia areata
- Compounded Hair Solutions and Foams Containing Minoxidil: Does the Color Change Impact Stability?
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Patchy hair loss in an otherwise healthy man
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience